CN100485036C - Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use - Google Patents

Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use Download PDF

Info

Publication number
CN100485036C
CN100485036C CNB2005100472287A CN200510047228A CN100485036C CN 100485036 C CN100485036 C CN 100485036C CN B2005100472287 A CNB2005100472287 A CN B2005100472287A CN 200510047228 A CN200510047228 A CN 200510047228A CN 100485036 C CN100485036 C CN 100485036C
Authority
CN
China
Prior art keywords
protein
gene
crustin
recombinant
renaturation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100472287A
Other languages
Chinese (zh)
Other versions
CN1936000A (en
Inventor
相建海
张继泉
李富花
王在照
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Oceanology of CAS
Original Assignee
Institute of Oceanology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Oceanology of CAS filed Critical Institute of Oceanology of CAS
Priority to CNB2005100472287A priority Critical patent/CN100485036C/en
Priority to PCT/CN2005/001560 priority patent/WO2007033529A1/en
Publication of CN1936000A publication Critical patent/CN1936000A/en
Application granted granted Critical
Publication of CN100485036C publication Critical patent/CN100485036C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

The invention relates to a Fenneropenaeus chinensis antimicrobial protein gene and the recombination expression and the application. It has the amino acid sequence of SEQ ID No.2 and basic group sequence of SEQ ID No.1 in sequence table. It selects the carrier of the antimicrobial protein pCR T7/NT TOPO TA and host bacterium BL21(DE3)pLysS that could high efficiently express recombination protein. Aimed at the feature of plural disulfide bonds, using the oxidation reduction system made of oxidized form of glutathione and glutathione in separating and purification and protein recombination process, the recombination protein with antimicrobial ability would be gained. The protein has strong inhibition to the growth of gram positivebacteria, and some inhibition to gram negativebacteria.

Description

A kind of Crustin antibiotic protein gene and recombinant expressed and application
Technical field
The present invention relates to antibacterial protein in the genetically engineered field (crustin) expression of gene, specifically a kind of Crustin antibiotic protein gene and recombinant expressed and application.
Background technology
Prawn culturing is one of mainstay industry of sea farming, and along with the continuous growth of market to high-quality fishery products demand, shrimp culture occupies more and more important position in aquaculture.Since nineteen nineties, the large-scale outbreak of disease makes mariculture industry suffer tremendous loss, and it is fundamentally controlled that the deterioration of antibiotic abuse and environment makes that the disease of marine cultured animal is difficult to.
The sea farming kind moves in the water surrounding that is rich in various microorganisms, and secular environmental stress makes it form effective defense function.Antibacterial peptide (albumen) is considered to one of main component of systems of defense such as fish, shrimp, shellfish.The 26S Proteasome Structure and Function of the antibacterial peptide gene by research sea farming kind, and then carry out recombinant expressedly external by genetic engineering technique, will promise to be and can substitute antibiotic newtype drug.
The immune defense system is the basis of zoonosis power, particularly hangs down and waits invertebrates, and their immune response is much simpler than higher animal, mainly depends on endogenous nonspecific immune reaction.Studies show that in recent years; hang down and wait invertebrates when external source harmful microorganism (as bacterium, fungi or virus) injury is avoided self in protection, non-specific antimicrobial factors in its body such as antibacterial peptide (albumen), N,O-Diacetylmuramidase, Transferrins,iron complexes etc. play important effect.Wherein, antibacterial peptide (albumen) is to compile the small molecule polypeptide (albumen) that produces by animal and plant cell specific gene, has anti-microbial activity.20th century the mid-1970s, Sweden scientist Boman etc. have obtained first kind of antibacterial peptide one cecropin (cecropin) in the world inducing with E.coli to separate when cherishing guppy giant silkworm (Hyatophora cecropia).After this, people find to exist similar polypeptide (albumen) with anti-microbial activity in succession in organisms such as other insect, Amphibians, Mammals, people, plant, crustacean, mollusk.Crustin is a kind of small molecular protein with very strong inhibition gram-positive bacteria activity that is obtained by separation and purification in beach crab (Carcinusmaenas) body such as Relf the earliest, himself is difficult for inactivation, even after being boiled, still can keep very high reactivity (J.M.Relf, J.R.S.Chisholm, G.D.Kemp and V.J.Smith, Purification and characterization of acysteine-rich 11.5-kDa antibacterial protein from the granular haemocytes ofthe shore crab, Carcinus maenas Eur.J.Biochem.1999; 264 (2): 350-357).After this, people have successively found the existence of crustin or antibacterial protein analogue (crustin-like) gene from shrimps such as Environment of Litopenaeus vannamei Low, white shore prawn, Japanese capsule prawn and tigar prawn.
The mechanism of action of crustin is different with traditional microbiotic, and its target site mainly is the pathogen cells film, therefore is difficult for producing resistance.At present, many pathogenic bacterias progressively produce resistance to existing microbiotic, and the discovery of new antibiotic is extremely difficult, and therefore, the research of crustin has been opened up wide prospect for the development of new antibacterials.
In a word, the research of crustin and its alloytype antibacterial peptide (albumen) not only has important significance for theories, also has huge application potential in practice, and therefore, it has become one of focus of current biological medicine research.
Summary of the invention
Purpose is to provide a kind of Crustin antibiotic protein gene and high efficiency recombinant expressed and application thereof.
Technical solution of the present invention is as follows:
Crustin antibiotic protein gene: have base sequence among the special tabulation SEQ ID No.1 and the aminoacid sequence shown in the SEQ ID No.2.
Described Crustin antibiotic protein gene recombinant expressed: from Crustin cDNA library, be cloned into a kind of antibiotic protein gene, utilize the gene constructed prokaryotic expression carrier of its mature peptide, filter out a kind of recombinant expression system that is used to efficiently express the Crustin antibiotic protein gene, acquisition contains the Laemmli buffer system Laemmli of the prokaryotic expression recombinant protein highly efficient renaturation of disulfide linkage, thereby obtains activated reorganization antibacterial protein; Be specially:
1. gene clone
According to pointing out of Crustin EST, utilize the RACE technology, from hemocyte cDNA library, clone goal gene;
2. the selection of recombinant expression vector and host bacterium
Determine to carry out recombinant expressed expression vector with the inclusion body form
Figure C200510047228D0004132354QIETU
T7/NT
Figure C200510047228D0004132412QIETU
TA and can alleviate the toxic host bacterium of destination gene expression product BL21 (DE3) pLysS;
3. the structure of recombinant expression vector
Utilize the feature of expression vector for the T carrier, adopt a pair of Auele Specific Primer clone mature peptide gene, the PCR product reclaims the back and directly is connected with expression, makes up recombinant expression vector;
4. transform and screening
With recombinant expression vector transformed into escherichia coli BL21 (DE3) pLysS that structure obtains, the screening engineering bacteria also carries out abduction delivering;
5. the separation and purification of expression product
Adopt inductor isopropyl-abduction delivering engineering bacteria, the ultrasonic disruption cell utilizes the method purifying antibacterial protein of metal-chelating column chromatography, protein renaturation, and the fusion tag excision obtains activated reorganization antibacterial protein;
Described protein renaturation adopts the Laemmli buffer system Laemmli of the prokaryotic expression recombinant protein highly efficient renaturation that contains disulfide linkage, adds Sleep-promoting factor B and reduced glutathion in renaturation buffered soln; Its concentration ratio: renaturation buffered soln (PBS): Sleep-promoting factor B: reduced glutathion=50:1:10; The renaturation pH value of buffer solution is 7.2 ~ 7.4;
Described a pair of Auele Specific Primer is:
CD-F:5’CAG?AAT?AAA?GAC?GAT?ACT?CG?3’;
CD-R:5’CTA?TCC?CTC?AGA?ACC?CAG?3’。
Described Crustin antibiotic protein gene is all inhibited to the growth of gram-positive microorganism and Gram-negative bacteria.
The present invention has following advantage:
1. the present invention has determined a kind of whole encoding sequences and non-coding sequence of Crustin antibiotic protein gene, thereby also understood fully amino acid preface and signal peptide cutting site thereof that it is coded, utilized the mature peptide aminoacid sequence of being derived to carry out recombinant expressed this gene.
2. the present invention filters out and can carry out recombinant expressed carrier of antibacterial protein and host bacterium effectively, has the proteic recombinant expressed foundation that provides of antibacterial to studying other.
3. the present invention provides a suitable redox system to the separation and purification and the protein renaturation of the recombinant protein that contains disulfide linkage, can effectively guarantee the correct formation of disulfide linkage in the recombinant protein.
4. of far-reaching significance.Can develop effective control medicine by the present invention to shrimp bacterial disease.Simultaneously, the research of separation and purification that other is had the recombinant expressed of antimicrobial active protein and be easy to the recombinant protein of oxidation provides new thinking.
Embodiment
Below in conjunction with embodiment the present invention is described in further detail.
Embodiment
A kind of clone's Crustin antibiotic protein gene has following sequence:
(1) information of SEQ ID No 1 (referring to sequence table)
(a) sequence signature:
* length: 523 base pairs
* type: nucleic acid
* chain: two strands
* topological framework: linearity
(b) molecule type: cDNA
(c) suppose: not
(d) antisense: not
(e) initial source: Crustin (Fenneropenaeus chinensis)
Sequence description: SEQ ID No.1
GAGTCCGTTCATCGCACAGCCGAGAGAAACACTATCAAGATGTTGAAGTTTGTAGTATTATCCGTTGTCGCCGTG
GCTGTGGTACACGCCCAGAATAAAGACGATACTCGCTTCCTTGGCGGAGTTCCTGGGGTTGGGGGTGGCTTCGTT
CCAGGGGTTCCTGGGCATGGCGGCGTTGCTCCTGTAGGCGGTGGCCTTGTCCCTGGCGGCGGTGCCTTATCCCT
GGAGGTGGATTCGAGTGCAATTACTGCAGAACGAGGTACGGATACGTATGCTGCAAGCCCGGCAGGTGTCCACCG
GTTCGCGACGTCTGCCCAGGCCTCAGGCAGGCAGGCTGTCCCGATCTGCCGTCAGGACACCGACTGTCGGCTCCGAC
AAATGCTGCTACGACGTCTGCTTGAACGACACCGTCTGCAAACCCATCGTGCTGGGTTCTGAGGGATAGGCCTGC
ATGTTTAACCCTTCAATTCTACTTTATTAAATAAATACTATAACTGTTAATTGCTTAAAAAAAAAAAAAAAAA
(2) information of SEQ ID No.2 (referring to sequence table)
(a) sequence signature
* length: 134 amino acid
* type: amino acid
* chain: strand
* topological framework: linearity
(b) molecule type: albumen
Sequence description: SEQ ID No.2
MLKFVVLSVVAVAVVHAQNKDDTRFLGGVPGVGGGFVPGVPGHGGVAPVGGGLVPGGGGLIPGGGFECN
YCRTRYGYVCCKPGRCPPVRDVCPGLRQGVPICRQDTDCFGSDKCCYDVCLNDTVCKPIVLGSEG
The Crustin gene in vitro is recombinant expressed, separation and purification and biological activity analysis:
From Crustin cDNA library, screen a kind of antibacterial protein (crustin) gene, utilize the gene constructed prokaryotic expression carrier of its mature peptide, filter out a kind of recombinant expression system that is used to efficiently express the Crustin antibiotic protein gene, find a kind of Laemmli buffer system Laemmli that is used to contain the prokaryotic expression recombinant protein highly efficient renaturation of disulfide linkage, obtained activated reorganization antibacterial protein.Specific as follows:
1) gene clone
According to the prompting of Crustin EST, utilize the RACE technology, from hemocyte cDNA library, clone goal gene;
2) selection of recombinant expression vector and host bacterium
Because the recombination expression product of goal gene has stronger bacteriostatic activity, the present invention screens present several business-like expression vectors and host bacterium, and has determined to carry out recombinant expressed carrier with the inclusion body form
Figure C200510047228D0006132611QIETU
T7/NT
Figure C200510047228D0006132559QIETU
TA and can alleviate the toxic host bacterium of destination gene expression product BL21 (DE3) pLysS.
Described recombinant expression system can be expressed antibacterial protein efficiently, and expression efficiency reaches 845mg/L.
3) structure of recombinant expression vector
Utilize the feature of expression vector for the T carrier, design a pair of Auele Specific Primer (CD-F:5 ' CAG AAT AAA GAC GAT ACT CG 3 '; CD-R:5 ' CTA TCC CTC AGA ACC CAG 3 ') clone's mature peptide gene, the PCR product reclaims the back and directly is connected with expression, makes up recombinant expression vector.
4) screening of abduction delivering and induced product
Recombinant expression vector is transformed expressive host bacterium BL21 (DE3) pLysS, in final concentration is the LB substratum of the penbritin of 100 μ g/mL and 34 μ g/mL paraxin, cultivate cell concentration to 0D 600Be about 0.6 (37 ℃ 250r/min), are added final concentration and carry out abduction delivering 4h for 1mmol/L IPTG; Adopt inductor isopropyl-(being called for short IPTG) screening abduction delivering engineering bacteria then.
5) separation and purification
After inducing end, the ultrasonic disruption cell utilizes the method purifying antibacterial protein of metal-chelating column chromatography, protein renaturation is specifically: centrifugal collection bacterium mud, and the weighing weight in wet base is by adding buffer A (50mmol/L sodium phosphate at 1: 10, the 6mol/L Guanidinium hydrochloride, 300mmol/L sodium-chlor, 1mmol/L Sleep-promoting factor B, the 10mmol/L reduced glutathion, pH7.2), ultrasonic disruption, 4 ℃, 12, centrifugal 30min under the 000r/min collects supernatant.Utilize Co-NTA-Agarose under the sex change condition, to carry out separation and purification.Recombinant protein after the separation and purification, containing 50mmol/L PBS damping fluid (the 1mmol/L Sleep-promoting factor B of 8mol/L, 4mol/L, 2mol/L, 1mol/L and 0.5mol/L urea successively, the 10mmol/L reduced glutathion, pH7.4) each 8h of dialysis in, Guanidinium hydrochloride in the lysate is replaced out, remove urea at 50mmol/L pH7.4 PBS damping fluid equilibrated Sephadex G-75 chromatography column, collect elutriant.
6) enzyme cuts except that fusion tag
The protein concentration of elutriant is diluted to 2mg/mL, utilizes the EKMax of Invitrogen company TMTest kit carry out fusion tag excision (25 ℃, 24h).
7) bacteriostatic experiment
Albumen behind the removal fusion tag is concentrated into 64 μ mol/L, simultaneously with the negative contrast of the PBS of 50mmol/L pH7.4.Utilize Oxford cup agar diffusion method to detect its bacteriostatic activity to gram-positive microorganism streptococcus aureus (Staphylococcusaureu), subtilis (Bacillus subtilis), micrococcus luteus (Micrococcus luteus) and Gram-negative bacteria intestinal bacteria (Escherichia coli), Vibrio anguillarum (Vibrio anguillarum).That is: with bacterial strain to be detected respectively at 37 ℃, overnight incubation under the 200r/min; Next day, centrifugal thalline also washed thalline 2 times with the PBS of the 50mmol/L pH7.4 that sterilizes, and utilized PBS dilution thalline to 10 6Cells/mL, get 100 μ l and evenly coat the LB planar surface, after in 37 ℃ of incubators, cultivating 2h, take out dull and stereotyped at the equidistant placement of agar surface Oxford cup, in the cup of Oxford, add the recombinant protein of different concns gradient, while as negative control, continues to cultivate 22h with PBS in 37 ℃ of incubators, take out observations.
The result shows that the recombinant protein of 4 μ mol/L can suppress the growth of the gram-positive microorganism (streptococcus aureus, subtilis and micrococcus luteus) that detected effectively, and the recombinant protein of 16 μ mol/L can suppress the growth of the Gram-negative bacteria (intestinal bacteria and Vibrio anguillarum) that detected effectively.
The successful clone of this gene and the bioactive evaluation of recombinant protein have the important application prospect in the exploitation of novel antibacterial medicine.
Sequence table
SEQUENCE?LISTING
<110〉Institute of Oceanology of the Chinese Academy of Sciences
<120〉a kind of Crustin antibiotic protein gene and recombinant expressed and application
<130>
<160>2
<170>PatentIn?version?3.1
<210>1
<211>523
<212>DNA
<213〉Crustin (Fenneropenaeus chinensis)
<220>
<221>ORF
<222> (40)..(444)
<223>
<400>1
Figure C200510047228D00081
Figure C200510047228D00091
<210>2
<211>134
<212>PRT
<213〉Crustin (Fenneropenaeus chinensis)
<400>2

Claims (5)

1. Crustin antibiotic protein gene, the base sequence that it is characterized in that this gene is the SEQ ID No.1 in the sequence table.
2. by the Crustin antibacterial protein of the described genes encoding of claim 1, it is characterized in that this proteic aminoacid sequence is the SEQ ID No.2 in the sequence table.
3. recombinant expressed method according to the described Crustin antibiotic protein gene of claim 1, it is characterized in that: from Crustin cDNA library, be cloned into a kind of antibiotic protein gene, utilize the gene constructed prokaryotic expression carrier of its mature peptide, filter out a kind of recombinant expression system that is used to efficiently express the Crustin antibiotic protein gene, acquisition contains the Laemmli buffer system Laemmli of the prokaryotic expression recombinant protein highly efficient renaturation of disulfide linkage, thereby obtains activated reorganization antibacterial protein; Be specially:
1) gene clone: according to the prompting of Crustin EST, utilize the RACE technology, from hemocyte cDNA library, clone goal gene;
2) selection of recombinant expression vector and host bacterium: determine to carry out recombinant expressed expression vector with the inclusion body form
Figure C200510047228C0002080857QIETU
T7/NT
Figure C200510047228C0002080838QIETU
TA and can alleviate the toxic host bacterium of destination gene expression product BL21 (DE3) pLysS;
3) structure of recombinant expression vector: utilize the feature of expression vector for the T carrier, adopt a pair of Auele Specific Primer clone mature peptide gene, the PCR product reclaims the back and directly is connected with expression, makes up recombinant expression vector;
4) transform and screening: with recombinant expression vector transformed into escherichia coli BL21 (DE3) pLysS that structure obtains, the screening engineering bacteria also carries out abduction delivering;
5) separation and purification of expression product: adopt inductor isopropyl-abduction delivering engineering bacteria, the ultrasonic disruption cell utilizes the method purifying antibacterial protein of metal-chelating column chromatography, protein renaturation, the fusion tag excision obtains activated reorganization antibacterial protein.
4. in accordance with the method for claim 3, it is characterized in that: described protein renaturation adopts the Laemmli buffer system Laemmli of the prokaryotic expression recombinant protein highly efficient renaturation that contains disulfide linkage, and Laemmli buffer system Laemmli is to add Sleep-promoting factor B and reduced glutathion in PBS renaturation buffered soln; PBS, Sleep-promoting factor B and reduced glutathion concentration ratio are 50:1:10 in the Laemmli buffer system Laemmli; PBS renaturation pH value of buffer solution is 7.2-7.4, and concentration is 50mmol/L.
5. it is characterized in that in accordance with the method for claim 3: described a pair of Auele Specific Primer is:
CD-F:5’?CAG?AAT?AAA?GAC?GAT?ACT?CG3’;
CD-R:5’?CTA?TCC?CTC?AGA?ACC?CAG3’。
CNB2005100472287A 2005-09-19 2005-09-19 Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use Expired - Fee Related CN100485036C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CNB2005100472287A CN100485036C (en) 2005-09-19 2005-09-19 Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use
PCT/CN2005/001560 WO2007033529A1 (en) 2005-09-19 2005-09-23 A gene encoding antibacterial protein of fenneropenaeus chinensis and its recombination expression method and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100472287A CN100485036C (en) 2005-09-19 2005-09-19 Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use

Publications (2)

Publication Number Publication Date
CN1936000A CN1936000A (en) 2007-03-28
CN100485036C true CN100485036C (en) 2009-05-06

Family

ID=37888525

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100472287A Expired - Fee Related CN100485036C (en) 2005-09-19 2005-09-19 Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use

Country Status (2)

Country Link
CN (1) CN100485036C (en)
WO (1) WO2007033529A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103539845B (en) * 2013-11-01 2016-05-11 中国科学院海洋研究所 A kind of synthetic polypeptide E and antiviral application thereof of ring-type
CN103539846B (en) * 2013-11-01 2016-05-11 中国科学院海洋研究所 A kind of synthetic polypeptide F of ring-type and anti-bacteria and anti-virus application thereof
CN103539849B (en) * 2013-11-01 2016-08-24 中国科学院海洋研究所 A kind of many PEPDs of ring-type synthesis and anti-bacteria and anti-virus application thereof
CN105255900A (en) * 2015-09-30 2016-01-20 中国科学院海洋研究所 Recombinant expression and application of reconstructed fenneropenaeus chinensiss antifungal protein gene ALFm
CN107201372B (en) * 2017-04-28 2020-12-15 中国水产科学研究院南海水产研究所 Penaeus monodon peroxide reductase 1 coding gene sequence and application thereof
CN109627310B (en) * 2019-01-10 2021-12-10 汕头大学 Method for extracting antimicrobial protein of Chinese mitten crab and food preservation application thereof
CN117327706A (en) * 2023-10-13 2024-01-02 江苏三仪生物工程有限公司 Composition for improving antiviral and immunity abilities of aquatic products and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1505681A (en) * 2001-03-12 2004-06-16 �ձ��̲ݲ�ҵ��ʽ���� A novel protein, a genes encoding therefor and a method of using the same
WO2005005613A2 (en) * 2003-07-02 2005-01-20 Medical University Of South Carolina Dsrna induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1171998C (en) * 2002-01-23 2004-10-20 山东大学 Antibacterial peptide gene of Chinese prawn and its colon technique
CN1194015C (en) * 2002-10-16 2005-03-23 武汉柏傲生物工程有限公司 Effective renaturation liquid of recombinant human interon inclusion body and renaturation method
US20040235738A1 (en) * 2003-05-16 2004-11-25 Academia Sinica Novel antimicrobial peptide isolated from penaeus monodon
CN1459506A (en) * 2003-05-30 2003-12-03 山东大学 Recombination expression and application of Chinese prawn antibacterial peptide gene
CN1654656A (en) * 2005-01-14 2005-08-17 中国科学院海洋研究所 FenneropenaeusChinensis Crustin gene and coded protein and cloning method therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1505681A (en) * 2001-03-12 2004-06-16 �ձ��̲ݲ�ҵ��ʽ���� A novel protein, a genes encoding therefor and a method of using the same
WO2005005613A2 (en) * 2003-07-02 2005-01-20 Medical University Of South Carolina Dsrna induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
抗真菌蛋白研究进展. 胡明,李晓宇,马平,朱宝成.生物技术通报,第3期. 2004 *

Also Published As

Publication number Publication date
WO2007033529A1 (en) 2007-03-29
CN1936000A (en) 2007-03-28

Similar Documents

Publication Publication Date Title
CN100485036C (en) Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use
CN102702333B (en) Drug-resistant pathogen infection resistant polypeptide and uses thereof
CN110643612B (en) Trachinotus ovatus antimicrobial peptide NK-lysin gene and application thereof
CN107383175A (en) A kind of antibacterial peptide VK 21 and its application
CN103789317A (en) Scylla paramamosain antibacterial peptide hyastatin gene clone, encoding protein recombination and application
CN111304181B (en) Genetically engineered vibrio parahemolyticus phage lyase and preparation method and application thereof
CN104263709A (en) Egg-white lysozyme and preparation method thereof
CN102417539A (en) Antibacterial protein and its coding gene, expression system, refolding system and application
CN101550183B (en) Antibacterial peptide and construction and application thereof
CN108396030B (en) Lifobinopenaeus antibacterial peptide gene Lv-BigPEN and recombinant protein and application thereof
CN101280021B (en) Engineered protein VP28-C against shrimp white spot syndrome virus, preparation and use thereof
CN107619444A (en) It is chimeric to wear film cecropin B gene 6N2 and its application
CN116063440B (en) Antibacterial peptide of delicious euglena and application thereof
CN102061303B (en) Fusion expression product of antimicrobial peptide genes of two marine animals and preparation method of fusion expression product
CN106795498B (en) Bacteriophage, compositions comprising same, and uses thereof
CN100345865C (en) Antibiotic dipeptide and its chemical modifier, its preparation method and uses
CN1459506A (en) Recombination expression and application of Chinese prawn antibacterial peptide gene
CN110294794A (en) A kind of Rhodopseudomonas palustris GroEL albumen and its preparation method and application
CN110295211A (en) A kind of preparation method and application of bacterium selenium-enriched protein
CN101942473A (en) Procambrus clarkii type i lysozyme gene, lysozyme coded by lysozyme gene and application of lysozyme
CN104447976A (en) Swine-derived antibacterial peptide cecropin P1 mutant as well as preparation method and application of swine-derived antibacterial peptide cecropin P1 mutant
CN102899331A (en) Complex duck interferon-alpha gene, and recombinant vector and application thereof
CN101565462B (en) Large yellow croaker BPI-BN protein, primer and applications thereof in preparing antibiotic drugs
CN103361341A (en) Genetic engineering expression and preparation methods of cecropin LL-37 and application thereof
CN101798573B (en) Totally-gene-synthesized dog alpha interferon gene and protein expression

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090506

Termination date: 20110919